Letter to the Editor: Remission of Graves’ Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis

  1. Casany-Fernandez, R.
  2. Gascon-Gimenez, F.
  3. Matarredona Solaz, E.J.
  4. Lozano, F.P.
  5. Dominguez-Moran, J.A.
  6. Ciscar, J.F.
  7. Real Collado, J.T.
Journal:
Thyroid

ISSN: 1557-9077 1050-7256

Year of publication: 2023

Volume: 33

Issue: 2

Pages: 267-269

Type: Letter

DOI: 10.1089/THY.2022.0398 GOOGLE SCHOLAR

Sustainable development goals